The IOPtiMate™ system utilizes a CO2 laser to locally thin the scleral tissue around Schlemm's Canal zone without penetrating the scleral wall. This system allows reducing IOP by facilitating adequate percolation of intra-ocular fluid from the anterior chamber through the remaining intact membrane. Percolation is achieved without penetrating the eye globe. The IOPtiMate™ system reduces the likelihood of complications commonly experienced with the current gold standard glaucoma treatment, i.e. trabeculectomy, which involves full thickness penetration.
IOPtima aims to achieve effective fluid filtration while minimizing the risk of perforating the remaining membrane, via the use of the IOPtiMate™ CO2 Laser Assisted Filtration Surgery system. Using the IOPtiMate™ in conjunction with the CO2 laser allows for a procedure where ablation is minimized once the desired scleral thickness has been achieved. This elegant surgical approach is possible because CO2 laser energy dissipates in water or aqueous solutions, thus inhibiting further ablation of scleral tissue as soon as it comes in contact with sufficient intra-ocular percolating fluid.
As an all-inclusive platform for laser-assisted filtration surgery, the IOPtiMate™ is designed to achieve functional, simple, reproducible filtration results with minimal complications.
The IOPtiMate™ is expected to make minimally invasive surgery attractive to eye surgeons in a safe, fast and cost effective manner.
IOPtiMate™ - Transforming Complex Glaucoma Surgery into Simple and Safe Procedure:
Alternative to penetrating Trabeculectomy
Minimally invasive filtration procedure
Low complication rates
High efficacy - Significant reduction of IOP (43%)
Substantial reduction of medications
Minimal learning curve, simple to operate
Cost effective (no consumables)
New opportunity for cutting-edge technology for differentiation in Glaucoma care
